New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MorePfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September. Source
Read MorePfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands
Read MoreThe HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products
Read MorePfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the
Read MoreThe FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the
Read MoreCash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial
Read MoreThe FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read MoreThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read MoreTravelers now need only one Covid-related document to enter Thailand — either a vaccination certificate or proof of a negative
Read More